Why is Gerald waiting to unveil in NYC?
First, he has
Why is Gerald waiting to unveil in NYC?
First, he has better control of the story in NYC unlike in Denmark. What media is going to cover him there? Lympro, if I am not mistaken, is initially geared for the United States. So, better that he unleash the news in the states at a conference where AMBS is the cosponser. There is no other story to get in the way like what would have been the case in Copenhagen.
2nd. As I touched above, more media outlets to get the story out. NYC just happens to be the #1 media market. What is Copenhagen? Get my point?
3rd. All the data isn't yet put together from what I gathered from what Gerald has written. The bridging of data isn't yet complete. Correct me if I am wrong.
In conclusion, NYC is the platform to launch Lympro. Bigger bang can be had there than in Copenhagen.
And some of you need to realize that ambs has a team that understands what they are doing. How many of you have ever done what they are doing? I doubt any, maybe one or two. Let the pros do their job while you relax behind your computer complaining about things that you really don't know about.
But if you have experience bringing diagnostics or drugs to market, please chime in so we can all get a better idea of how difficult and complex it is in today's highly regulated environment.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Earnings Date: Mark Your Calendar Well, folks, the date is set. ePlus Inc. is gearing up to drop some numbers that could stir the markets a bit. Come November 5th, those eagle-eyed investors better be on their toes because that’s when we’re getting the scoop on ePlus' second-quarter results for the fiscal year 2027. The bell rings after the market closes, so pour...
Continue Reading
Another Big Win in Phoenix's Industrial Space Who'd have thought? Dircks Moving & Logistics just bagged themselves a hefty 337,897-square-foot lease in Phoenix. This isn’t just any warehouse deal in the Southwest Valley—it’s a mark of where the industrial real estate world’s trending these days. For those who watch these things, they’ve pushed their local space...
Continue Reading
Staggering Numbers From Texas Crashes Reveal a Sobering Truth When you peel back the layers on Texas's latest alcohol-related crash data, you're looking at a grim picture painted by Grossman Law Offices. In a state that's no stranger to big numbers and even bigger drinks, finding that half of these crashes had a blood alcohol content (BAC) over twice the legal limit makes...
Continue Reading
Rough Waves for FIS Shareholders If there’s one thing I've learned chewing on greasy bacon over the years, it's that nothing rattles a stock like sketchy numbers and shattered investor confidence. Fidelity National Information Services, or FIS, has just yanked the rug out from its own 2026 forecast, cutting adjusted earnings per share (EPS) to a range of $5.82 to $5.89....
Continue Reading
Playing Chicken with Federal Deadlines We've got ourselves a situation where defense contractors are juggling bigger backlogs while the clock ticks down to a looming federal funding deadline on December 11. If this sounds like a high-stakes game of chicken, it's because it is. No one knows if Congress will stitch things up before the stopgap funding dries up. Hell, maybe...
Continue Reading
Sealing the Deal with Strategic Long-term Goals Alright, here’s the scoop straight outta Dortmund. Borussia Dortmund and SPORTFIVE have penned themselves a cushy deal lasting till 2034. That’s right—eight more solid years. Talk about shuffling the deck with some planning foresight, huh? Been hitting shoulders since '99, these two, so this ain’t just another...
Continue Reading
No one just stumbles into 400 successful deals without a whole lot of grit, especially in the gnarly jungle of health care services mergers and acquisitions. The Braff Group, a stalwart in this arena since 1998, has just hit this remarkable milestone. If you ask me, this isn't just a number—it's a testament to the blood, sweat, and relentless dedication poured into...
Continue Reading
Core's Strong Q3: A Closer Look The latest buzz in the coal sector is all about Core Natural Resources, Inc. (NYSE: CNR) delivering a sturdy third quarter performance. These folks are playing the market like a fiddle, dishing out $9 million in net income and clocking $165.2 million in adjusted EBITDA. For a sector rife with dust and sweat, that's not too shabby. A Closer...
Continue Reading
Inside the Baanx Data Breach: A Wake-Up Call The digital currency frontier is fraught with pitfalls, and the latest Baanx data breach saga is a sobering reminder. This isn't just a minor fumble—this one's a big, hairy mess involving sensitive data of Crypto Life users, causing ripples through an already jittery market. What Went Wrong with Baanx We're staring at...
Continue Reading
DeFi Technologies Sets the Stage for Q3 Results When it comes to stirring the pot, DeFi Technologies sure knows how to do it. They're not just flipping the calendar; they're gearing up to lay bare their Q3 2026 financials. The big show? It happens live on November 13, 2026, at 11:00 a.m. EST. Get your coffee ready because you don't want to miss this shareholder call where...
Continue Reading
Top 5 Most Recently Viewed Articles
Prepare for the Enchantment of LuminoCity Festival LuminoCity Festival is back, bringing a unique blend of magic and joy to Eisenhower Park. This spectacular event transforms the season into a breathtaking experience filled with delightful lights and captivating displays inviting the community to celebrate together. Every year, LuminoCity Festival offers an innovative...
Continue Reading
Akeso's Ivonescimab Study Makes Headlines AKESO Inc. has recently made an impressive announcement regarding its Phase III clinical trial of ivonescimab, a pioneering treatment for advanced squamous non-small cell lung cancer (sq-NSCLC). The groundbreaking results from the AK112-306/HARMONi-6 study have gained acceptance for publication in The Lancet, a highly respected...
Continue Reading
Reimagining Emergency Loans for Borrowers with Bad Credit In the ever-evolving world of financial services, RadCred is making a significant impact with their unique approach to assisting individuals with poor credit scores. Their innovative, AI-powered platform connects borrowers with licensed lenders, making emergency loans more accessible for those who often face...
Continue Reading
NCR Atleos Expands Cashzone Network to Italy NCR Atleos Corporation (NYSE: NATL), a frontrunner in enhancing self-service financial access, has proudly announced its expansion of the Cashzone ATM network into Italy. This move is designed to offer both residents and tourists a streamlined means to access cash efficiently. This expansion represents a significant milestone,...
Continue Reading
The Times Are A-Changing in Dental Offices Picture a bustling morning in a dental office, with staff juggling appointments like plates at a circus. The phone’s ringing, someone needs scheduling, insurance checks pile up—all while ensuring patients don't feel like a cog in the machine. Amidst this chaos, Annie, the dental startup out of Utah, steps up with a fresh...
Continue Reading